Avid Bioservices Inc operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Avid Bioservices Inc with three other
pharmaceutical manufacturers in North America:
sales of $32.66 million
of which 100%
was commercial-stage diagnostics),
C21 Investments Inc
(49.93 million Canadian Dollars [US$37.21 million]
Medexus Pharmaceuticals Inc
based in CANADA
(74.36 million Canadian Dollars [US$55.41 million]
Avid Bioservices Inc reported sales of $59.70 million
April of 2020.
increase of 11.4%
versus 2019, when the company's sales were $53.60 million.